The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Evaluation of amitriptyline in primary fibrositis. A double‐blind, placebo‐controlled study
Abstract
Seventy patients with primary fibrositis satisfying Smythe's criteria were studied in a 9‐week double‐blind trial comparing 50 mg amitriptyline with placebo. Fifty‐nine patients completed the trial: 27 were treated with amitriptyline, and 32 took a placebo. The patients who received amitriptyline improved significantly in their morning stiffness and pain analog scores at 5 and 9 weeks, compared with baseline scores, whereas no changes were noted in these parameters in the placebo group. Fibrositic point tenderness did not improve significantly in either of the treatment groups. When compared with the placebo group, the amitriptyline group improved significantly with respect to sleep pattern and patient and physician global assessments. Our data indicate that amitriptyline has some therapeutic benefit in patients with primary fibrositis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Huskisson, E. C. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90884-8 · Cited by 4,522
Primary fibromyalgia (fibrositis): Clinical study of 50 patients with matched normal controls
Yunus, M., Masi, A. T., Calabro, J. J., Miller, K. A., & Feigenbaum, S. L. (1981) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(81)90096-2 · Cited by 910
Moldofsky, H., Scarisbrick, P., England, R., & Smythe, H. (1975) · Psychosomatic Medicine · doi:10.1097/00006842-197507000-00008 · Cited by 854
Induction of Neurasthenic Musculoskeletal Pain Syndrome by Selective Sleep Stage Deprivation
Moldofsky, H., & Scarisbrick, P. (1976) · Psychosomatic Medicine · doi:10.1097/00006842-197601000-00006 · Cited by 564
Two contributions to understanding of the "fibrositis" syndrome.
SMYTHE, H. A., & Moldofsky, H. (1977) · PubMed · Cited by 314
Prevalence of primary and secondary fibrositis.
Wolfe, F., & Cathey, M. A. (1983) · PubMed · Cited by 199
Moldofsky, H., Scarisbrick, P., England, R., & Smythe, H. (1976) · Pain · doi:10.1016/0304-3959(76)90036-1 · Cited by 196
Moldofsky, H., & Lue, F. A. (1980) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(80)90324-7 · Cited by 162
Plasma tryptophan and musculoskeletal pain in non-articular rheumatism (“fibrositis syndrome”)
Moldofsky, H., & Warsh, J. J. (1978) · Pain · doi:10.1016/0304-3959(78)90025-8 · Cited by 116
Preference for endpoint measures in clinical trials: results of structured workshops.
Bombardier, C., Tugwell, P., Sinclair, A., Dok, C., Anderson, G., & Ww, B. (1982) · PubMed · Cited by 106
Hartmann, E. L., & Cravens, J. (1973) · Psychopharmacology · doi:10.1007/bf00429086 · Cited by 101
Interaction of EEG sleep, antidepressants, and affective disease.
Hd, K., & Riordan, C. E. (1982) · PubMed · Cited by 85
Amitriptyline and EEG Sleep in Depressed Patients: I. Drug Effect
David, J. K., Duane, G. S., Coble, P. A., & Richard, J. M. (1978) · SLEEP · doi:10.1093/sleep/1.2.149 · Cited by 74
Hartmann, E. L., & Cravens, J. (1973) · Psychopharmacology · doi:10.1007/bf00429087 · Cited by 59
Saletu, B., Allen, M., & Itil, T. M. (1974) · Pharmacopsychiatry · doi:10.1055/s-0028-1094435 · Cited by 11
Cited by
Functional somatic syndromes: one or many?
Wessely, S., Nimnuan, C., & Sharpe, M. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08320-2 · Cited by 1,211
Management of fibromyalgia syndrome
Goldenberg, D. L. (2004) · JAMA · doi:10.1001/jama.292.19.2388 · Cited by 850
“In 1986, 2 RCTs demonstrated modest effectiveness of amitriptyline (25-50 mg at bedtime).(37,38) Other RCTs confirmed these results during the next decade.”
BackgroundOnghena, P., & Van Houdenhove, B. (1992) · Pain · doi:10.1016/0304-3959(92)90144-z · Cited by 563
Antidepressant Treatment of Fibromyalgia: A Meta-Analysis and Review
Arnold, L. M., Keck, P. E., & Welge, J. A. (2000) · Psychosomatics · doi:10.1176/appi.psy.41.2.104 · Cited by 448
Goldenberg, D. L., Felson, D. T., & Dinerman, H. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291110 · Cited by 439
Metadata
- Authors
- Carette, S., McCain, G. A., Bell, D. A., & Fam, A. G.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1986-05
- Volume
- 29
- Issue
- 5
- Pages
- 655-659
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2149263581
- Cited by
- 303
- References
- 15
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.